Improving Outcomes in Cancer Patients on Oral Anti-Cancer Medications Using a Multi-modal Mobile Health Intervention
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Dana-Farber Cancer Institute
Related studies linked through entity extraction aliases.
Study of Bortezomib,Lenalidomide,Dexamethasone & Elotuzumab in Newly Diagnosed MM
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab After ASCT for Hodgkin Lymphoma, DLBCL and T-NHL
- Status
- COMPLETED
- Phase
- PHASE2
Patient-Centered Care for the Older Adult With Hematologic Malignancy
- Status
- COMPLETED
- Phase
- NA
Bone Mineral Density Status in Pediatric and Adolescent Survivors of Childhood Cancer With History of Bone Fracture
- Status
- COMPLETED
- Phase
- N/A
A Phase II Trial of Low-Dose Interleukin-2 (IL-2) Added to Extra-Corporeal Photopheresis for Steroid-Refractory cGVHD
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab +/- Bevacizumab for Recurrent GBM
- Status
- COMPLETED
- Phase
- PHASE2
Evaluating Mass Spectrometry And Intraoperative MRI In The Advanced Multimodality Image Guided Operating Suite (Amigo) In Breast-Conserving Therapy
- Status
- COMPLETED
- Phase
- NA
T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCA
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Individual Adult and Pediatric Patient Dose-escalated Interleukin-2 Therapy for Refractory Chronic GVHD
- Status
- COMPLETED
- Phase
- PHASE1
Sorafenib and Cyclophosphamide/Topotecan in Patients With Relapsed and Refractory Neuroblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Sexual Therapy and Rehabilitation After Treatment for Ovarian Cancer (START-OC): A Pilot Intervention
- Status
- COMPLETED
- Phase
- NA
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of MEK162 for Children With Low-Grade Gliomas
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Parental Decision-Making for Children With Relapsed Neuroblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Improving Informed Consent for Palliative Chemotherapy
- Status
- COMPLETED
- Phase
- NA
E-PRISM: Phase II Trial of Elotuzumab Lenalidomide and Dexamethasone in High-Risk Smoldering Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
A Prospective Study of Plasma Genotyping as a Noninvasive Biomarker for Genotype-directed Cancer Care
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Prospective CiRculating prOstate Cancer Predictors in HighEr Risk mCRPC studY
- Status
- COMPLETED
- Phase
- N/A
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
- Status
- RECRUITING
- Phase
- N/A